Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2018

Cushing MM, Kelley J, Klapper E, Friedman DF, Goel R, Heddle NM, et al. Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine Committee. Transfusion. 2018;58(4):1065-1075.

Liu D, Takhar M, Alshalalfa M, Erho N, Shoag J, Jenkins RB, et al. Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer. JCO Precis Oncol. 2018;2018.

Chen Y-, Chen Z, Du Y-. Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells. Oncotarget. 2018;9(30):20941-20952.

Mechery V, Hernandez T, Mathew AT, Wanchoo R, Seshan SV, Jhaveri KD, et al. Nephropathology Education During Nephrology Fellowship Training in the United States. Kidney Int Rep. 2018;3(2):236-241.

Goyal A, Zhang G, Yang B. Differential expression patterns of GATA3 in usual and differentiated types of vulvar intraepithelial neoplasia: potential diagnostic implications. Mod Pathol. 2018;31(7):1131-1140.

Alves CP, Dey-Guha I, Kabraji S, Yeh AC, Talele NP, Solé X, et al. AKT1 Quiescent Cancer Cells Promote Solid Tumor Growth. Mol Cancer Ther. 2018;17(1):254-263.

Georgesen C, Huang J, Avarbock A, Harp J, Magro C. Orofacial granulomatosis and erythema multiforme in an adolescent with Crohn's disease. Pediatr Dermatol. 2018;35(5):e294-e297.

Morrone KA, Pecker LH, Rand J, Davila J, Oyeku S, Little JA, et al. Association of silent infarcts in sickle cell anemia with decreased annexin A5 resistance. Blood Cells Mol Dis. 2018;69:53-56.

Cheng S, Inghirami G, Cheng S, Tam W. Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL. J Hematol Oncol. 2018;11(1):105.

Bellazzo A, Di Minin G, Valentino E, Sicari D, Torre D, Marchionni L, et al. Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells. Cell Death Differ. 2018;25(7):1224-1238.